Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares Outstanding
Ratios

Tandem Diabetes Care (TNDM) Cost of Revenue (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Cost of Revenue readings, the most recent being $122.9 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 1.81% to $122.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $468.7 million, a 4.02% increase, with the full-year FY2025 number at $468.7 million, up 4.02% from a year prior.
  • Cost of Revenue hit $122.9 million in Q4 2025 for Tandem Diabetes Care, up from $115.0 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $125.2 million in Q4 2024 to a low of $67.8 million in Q1 2021.
  • Median Cost of Revenue over the past 5 years was $99.2 million (2022), compared with a mean of $100.7 million.
  • Biggest five-year swings in Cost of Revenue: surged 45.29% in 2021 and later fell 4.25% in 2023.
  • Tandem Diabetes Care's Cost of Revenue stood at $96.3 million in 2021, then increased by 9.05% to $105.0 million in 2022, then decreased by 1.41% to $103.5 million in 2023, then increased by 20.96% to $125.2 million in 2024, then fell by 1.81% to $122.9 million in 2025.
  • The last three reported values for Cost of Revenue were $122.9 million (Q4 2025), $115.0 million (Q3 2025), and $114.8 million (Q2 2025) per Business Quant data.